<p>，/PRNewswire/ -- Ademi 律師事務所正在調查 VYNE（納斯達克：VYNE）在其最近宣佈與 Yarrow Bioscience 的交易中可能存在的信託責任違反和其他法律違規行為。</p>
<p>點擊這裏瞭解如何加入我們的調查並獲取更多信息，或通過 [email protected] 與我們聯繫，或撥打免費電話：866-264-3995。您無需支付任何費用或承擔任何義務。</p>
<p>在此次交易中，VYNE 股東將獲得合併前 VYNE 股東預計將擁有合併後公司約 3% 的股份，而合併前 Yarrow 股東預計將擁有合併後公司約 97% 的股份。VYNE 內部人士將作為控制權變更安排的一部分獲得可觀的利益。</p>
<p>交易協議不合理地限制了 VYNE 的競爭交易，若 VYNE 接受競爭報價將面臨重大罰款。我們正在調查 VYNE 董事會的行為，以及他們是否履行了對所有股東的信託責任。</p>
<p>我們專注於涉及收購、合併和個人股東權利的股東訴訟。如需更多信息，請隨時致電我們。律師廣告。以往的結果並不保證類似的結果。</p>
<p>聯繫方式</p>
<p>Ademi &amp; Fruchter LLP</p>
<p>Guri Ademi</p>
<p>免費電話：(866) 264-3995</p>
<p>傳真：(414) 482-8001</p>
<p>來源：Ademi LLP</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjE4Jk5ld3NJdGVtSWQ9Q0c1MTM2MSZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMTgxOTM5UFJfTkVXU19VU1BSX19fX19DRzUxMzYx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjE4Jk5ld3NJdGVtSWQ9Q0c1MTM2MSZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMTgxOTM5UFJfTkVXU19VU1BSX19fX19DRzUxMzYx"/></p>

VYNE

<p>Ademi 律師事務所正在調查 VYNE Therapeutics Inc.在與 Yarrow Bioscience 的交易中是否存在潛在的信託責任違反。VYNE 的股東將擁有合併公司約 3% 的股份，而 Yarrow 的股東將擁有 97% 的股份。該交易限制了對 VYNE 的競爭性出價，內部人士獲得了可觀的利益。調查的重點是 VYNE 董事會是否履行了對股東的信託責任</p>

<p>, /PRNewswire/ -- The Ademi Firm is investigating VYNE (Nasdaq: VYNE) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Yarrow Bioscience.</p>
<div class="lb-trans"><p>，/PRNewswire/ -- Ademi 律師事務所正在調查 VYNE（納斯達克：VYNE）在其最近宣佈與 Yarrow Bioscience 的交易中可能存在的信託責任違反和其他法律違規行為。</p>
</div><p>Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.</p>
<div class="lb-trans"><p>點擊這裏瞭解如何加入我們的調查並獲取更多信息，或通過 [email protected] 與我們聯繫，或撥打免費電話：866-264-3995。您無需支付任何費用或承擔任何義務。</p>
</div><p>In the transaction, VYNE shareholders will receive the pre-Merger VYNE stockholders are expected to own approximately 3% of the combined company, and the pre-Merger Yarrow stockholders are expected to own approximately 97% of the combined company. VYNE insiders will receive substantial benefits as part of change of control arrangements.</p>
<div class="lb-trans"><p>在此次交易中，VYNE 股東將獲得合併前 VYNE 股東預計將擁有合併後公司約 3% 的股份，而合併前 Yarrow 股東預計將擁有合併後公司約 97% 的股份。VYNE 內部人士將作為控制權變更安排的一部分獲得可觀的利益。</p>
</div><p>The transaction agreement unreasonably limits competing transactions for VYNE by imposing a significant penalty if VYNE accepts a competing bid. We are investigating the conduct of the VYNE board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.</p>
<div class="lb-trans"><p>交易協議不合理地限制了 VYNE 的競爭交易，若 VYNE 接受競爭報價將面臨重大罰款。我們正在調查 VYNE 董事會的行為，以及他們是否履行了對所有股東的信託責任。</p>
</div><p>We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.</p>
<div class="lb-trans"><p>我們專注於涉及收購、合併和個人股東權利的股東訴訟。如需更多信息，請隨時致電我們。律師廣告。以往的結果並不保證類似的結果。</p>
</div><p>Contacts</p>
<div class="lb-trans"><p>聯繫方式</p>
</div><p>Ademi &amp; Fruchter LLP</p>
<div class="lb-trans"><p>Ademi &amp; Fruchter LLP</p>
</div><p>Guri Ademi</p>
<div class="lb-trans"><p>Guri Ademi</p>
</div><p>Toll Free: (866) 264-3995</p>
<div class="lb-trans"><p>免費電話：(866) 264-3995</p>
</div><p>Fax: (414) 482-8001</p>
<div class="lb-trans"><p>傳真：(414) 482-8001</p>
</div><p>SOURCE Ademi LLP</p>
<div class="lb-trans"><p>來源：Ademi LLP</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjE4Jk5ld3NJdGVtSWQ9Q0c1MTM2MSZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMTgxOTM5UFJfTkVXU19VU1BSX19fX19DRzUxMzYx" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=CG51361&amp;Transmission_Id=202512181939PR_NEWS_USPR_____CG51361&amp;DateId=20251218"/></p>

19:39 ET
			
			
				Shareholder Alert: The Ademi Firm investigates whether VYNE Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders

股東警示：Ademi 律師事務所正在調查 VYNE Therapeutics Inc.是否為其公眾股東爭取到了公平的價格